Skip to main content
Equibles

SOPH · SOPHiA GENETICS SA · Metrics

Track SOPH — free

Use SOPH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SOPH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.35 +0.30 (+4.26%) At close · Oct 23
Rebalance outlook locked
Market Cap
$625.69M
Shares
85.13M
Volume · Oct 23 455.64K Avg daily vol (3M) 590.67K

SOPH metrics

74 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$7.35
Market cap
$625.69M

Price action

20 metrics
Price change (1W)
+9.2%
Price change (30D)
-11.9%
Price change (3M)
+28.5%
Price change (6M)
+51.5%
Price change (YTD)
+57.4%
Price change (1Y)
+78.4%
Trailing year
Price change (5Y)
-52.3%
52-week high
$8.92
52-week low
$3.89
Change from 52-week high
-17.6%
Change from 52-week low
+88.9%
Annualized volatility
64.2%
Annualized volatility (3M)
77.6%
Beta
1.4
RSI (14D)
48.5
Price vs SMA 50
-6.8%
Price vs SMA 200
+24.9%
Avg volume (3M)
590,674
Relative volume
0.8
Average dollar volume
$4.57M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
85.13M

Valuation

12 metrics
P / E (TTM)
8.1
Trailing earnings · reciprocal yield 12.3%
PEG ratio
—
EV / revenue
6.6×
reciprocal yield 15.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
7.3×
reciprocal yield 13.8%
P / book
7.5
reciprocal yield 13.3%
FCF yield
-6.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
12.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-03
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
66.6%
Operating margin
-85.5%
Trailing 12 months
Net margin
89.5%
Gross profit (TTM)
$57.41M
Operating profit (TTM)
−$73.71M
Net income (TTM)
$77.12M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.69

Growth

11 metrics
Revenue growth YoY
+27.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$86.17M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.7%
Year over year · more shares
Revenue CAGR (3Y)
+17.6%
Revenue CAGR (5Y)
+22.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
92.8%
Return on assets
38.9%
Debt / equity
0.6
Current ratio
2.7
EBITDA (TTM)
−$63.19M
Free cash flow (TTM)
−$41.21M
Quick ratio
2.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$59.67M
Latest balance sheet
Cash & equivalents
$107.67M
Total assets
$198.36M
Total debt
$48.00M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$39.74M
Capital expenditures (TTM)
$1.47M
R&D (TTM)
$34.80M
SG&A (TTM)
−$96.17M
Stock compensation (TTM)
$15.82M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
72
13F filer change QoQ
+22
Institutional ownership
44.0%
Conviction holders (share of 13F filers)
1.4%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+51.9%
Holder tenure
8.7
Price vs estimated holder cost
-24.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
1.3%
Latest settlement · 1.7 days to cover
Days to cover
1.7d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$2.26M
Insider-sentiment score
45 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1840706 CUSIP H82027105 13F (30d) 10 filings 10 filers Visit website Investor relations